Monocyclic heterocycles as kinase inhibitors
US7459562B2 · kind B2 · utility
21Cited by
32References
17Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 21, 2005 |
| Grant date | Dec 2, 2008 |
| Priority date | — |
| Expiry date | May 17, 2026 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D417/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed to compounds having the formulaand methods for using them for the treatment of cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.